Risk for cardiovascular disease early and late after a diagnosis of giant-cell arteritis: A cohort study

Annals of Internal Medicine

Volumn 160, Issue 2, 2014, Pages 73-80

  Tomasson, Gunnar ^a   Peloquin, Christine ^b   Mohammad, Aladdin ^c   Love, Thorvardur J ^a   Zhang, Yuqing ^b   Choi, Hyon K ^b   Merkel, Peter A ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b BOSTON UNIVERSITY   (United States)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; NITRATE;

AGED; ARTICLE; BLOOD VESSEL BIOPSY; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DRUG USE; ELECTRONIC MEDICAL RECORD; FEMALE; FOLLOW UP; GIANT CELL ARTERITIS; HEART INFARCTION; HUMAN; HYPERTENSION; INCIDENCE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; TOBACCO USE;

AGED; CARDIOVASCULAR DISEASES; COHORT STUDIES; FEMALE; GIANT CELL ARTERITIS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERIPHERAL VASCULAR DISEASES; RISK FACTORS; STROKE;

EID: 84893337374     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M12-3046     Document Type: Article

References (25)

1. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum. 1990;33:1122-8. [PMID: 2202311]
2. Lie JT. Illustrated histopathologic classification criteria for selected vasculitis syndromes. American College of Rheumatology Subcommittee on Classification of Vasculitis. Arthritis Rheum. 1990;33:1074-87. [PMID: 1975173]
3. González-Gay MA, Blanco R, Rodríguez-Valverde V, Martínez-Taboada VM, Delgado-Rodriguez M, Figueroa M, et al. Permanent visual loss and cerebrovascular accidents in giant cell arteritis: predictors and response to treatment. Arthritis Rheum. 1998;41:1497-504. [PMID: 9704651]
4. Liozon E, Herrmann F, Ly K, Robert PY, Loustaud V, Soria P, et al. Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients. Am J Med. 2001;111:211-7. [PMID: 11530032]
5. Agard C, Barrier JH, Dupas B, Ponge T, Mahr A, Fradet G, et al. Aortic involvement in recent-onset giant cell (temporal) arteritis: a case-control prospective study using helical aortic computed tomodensitometric scan. Arthritis Rheum. 2008;59:670-6. [PMID: 18438900]
6. Nuenninghoff DM, Hunder GG, Christianson TJ, McClelland RL, Matteson EL. Incidence and predictors of large-artery complication (aortic aneurysm, aortic dissection, and/or large-artery stenosis) in patients with giant cell arteritis: a population-based study over 50 years. Arthritis Rheum. 2003;48:3522-31. [PMID: 14674004]
7. Ray JG, Mamdani MM, Geerts WH. Giant cell arteritis and cardiovascular disease in older adults. Heart. 2005;91:324-8. [PMID: 15710711]
8. Molloy ES, Kirchner HL, Murray PK, Hoffman GS, Langford CA. Cardiovascular outcomes in giant cell arteritis. Presented at the American College of Rheumatology Annual Scientific Meeting, Boston, Massachusetts, 6-11 November 2007. Abstract no. 1235.
9. Duhaut P, Pinede L, Demolombe-Rague S, Loire R, Seydoux D, Ninet J, et al. Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes. Arthritis Rheum. 1998;41:1960-5. [PMID: 9811050]
10. Gonzalez-Gay MA, Piñeiro A, Gomez-Gigirey A, Garcia-Porrua C, Pego-Reigosa R, Dierssen-Sotos T, et al. Influence of traditional risk factors of atherosclerosis in the development of severe ischemic complications in giant cell arteritis. Medicine (Baltimore). 2004;83:342-7. [PMID: 15525846]
11. Larsson K, Mellström D, Nordborg E, Nordborg C, Odén A, Nordborg E. Early menopause, low body mass index, and smoking are independent risk factors for developing giant cell arteritis. Ann Rheum Dis. 2006;65:529-32. [PMID: 16126796]
12. Loddenkemper T, Sharma P, Katzan I, Plant GT. Risk factors for early visual deterioration in temporal arteritis. J Neurol Neurosurg Psychiatry. 2007;78:1255-9. [PMID: 17504884]
13. Simon C. Overview of the GP Contract. InnovAiT. 2008;1:134-9.
14. Stuart-Buttle CD, Read JD, Sanderson HF, Sutton YM. A language of health in action: Read Codes, classifications and groupings. Proc AMIA Annu Fall Symp. 1996:75-9. [PMID: 8947631]
15. Schafer JL. Analysis of Incomplete Multivariate Data. 1st ed. London: Chapman & Hall/CRC; 1997.
16. Hernán MA. The hazards of hazard ratios. Epidemiology. 2010;21:13-5. [PMID: 20010207]
17. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc. 1999;94:496-509.
18. Hoffman GS, Cid MC, Hellmann DB, Guillevin L, Stone JH, Schousboe J, et al; International Network for the Study of Systemic Vasculitides. A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis. Arthritis Rheum. 2002;46:1309-18. [PMID: 12115238]
19. Salvarani C, Cimino L, Macchioni P, Consonni D, Cantini F, Bajocchi G, et al. Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis. Arthritis Rheum. 2005;53:293-7. [PMID: 15818722]
20. Sholter DE, Armstrong PW. Adverse effects of corticosteroids on the cardiovascular system. Can J Cardiol. 2000;16:505-11. [PMID: 10787466]
21. Fang F, Fall K, Mittleman MA, Sparén P, Ye W, Adami HO, et al. Suicide and cardiovascular death after a cancer diagnosis. N Engl J Med. 2012;366:1310-8. [PMID: 22475594]
22. Weijenberg MP, Feskens EJ, Kromhout D. Total and high density lipoprotein cholesterol as risk factors for coronary heart disease in elderly men during 5 years of follow-up. The Zutphen Elderly Study. Am J Epidemiol. 1996;143:151-8. [PMID: 8546116]
23. Manzi S, Meilahn EN, Rairie JE, Conte CG, Medsger TA Jr, Jansen-McWilliams L, et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study. Am J Epidemiol. 1997;145:408-15. [PMID: 9048514]
24. Solomon DH, Karlson EW, Rimm EB, Cannuscio CC, Mandl LA, Manson JE, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303-7. [PMID: 12628952]
25. Suppiah R, Judge A, Batra R, Flossmann O, Harper L, Höglund P, et al. A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis. Arthritis Care Res (Hoboken). 2011;63:588-96. [PMID: 21452269] and Skin Diseases